| Dr Muneeb Rahman, MD | |
|
246 Pleasant St Bldg West, Concord, NH 03301-2548 | |
| (603) 224-9661 | |
| (603) 227-7528 |
| Full Name | Dr Muneeb Rahman |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 9 Years |
| Location | 246 Pleasant St Bldg West, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588011324 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Concord Hospital | Concord, NH | Hospital |
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Concord Hospital Inc | 6103721790 | 462 |
News Archive
Aerocrine AB (STO:AEROB) today announced that Health Canada's Therapeutic Products Directorate has approved Aerocrine's NIOX MINO® technology for use in treating asthma. Canada's National Health Service may now begin using the NIOX MINO, a medical device that provides a measure of the degree of inflammation in the airways in a single breath.
Flatcracker Software announced the release of Lady Biz 3.0, a specially designed iPhone application that enables women to record and track vital daily health details including menstruation details, sleep patterns, waking temperature, weight, and more.
NPR's "All Things Considered" examines HIV/AIDS treatment progress in developing countries, where the high cost of the "triple-drug regimens that were routinely saving the lives of patients in wealthier countries," and logistical issues, such as ensuring patients would take their medication on time, led some experts to say HIV treatment was "impossible" in the earlier years of the epidemic.
Sangamo BioSciences, Inc., a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire plc, have agreed to revise their January 2012 collaboration and license agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington's disease.
Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for the use of their novel mitochondrial pore modulator, TRO40303, for cytoprotection. The patent provides coverage for the use of Trophos' TRO40303 to reduce the cardiac reperfusion injury that contributes significantly to the morbidity and mortality seen after a heart attack (myocardial infarction - MI).
› Verified 7 days ago
| Entity Name | Concord Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194778571 PECOS PAC ID: 6103721790 Enrollment ID: O20040405000916 |
News Archive
Aerocrine AB (STO:AEROB) today announced that Health Canada's Therapeutic Products Directorate has approved Aerocrine's NIOX MINO® technology for use in treating asthma. Canada's National Health Service may now begin using the NIOX MINO, a medical device that provides a measure of the degree of inflammation in the airways in a single breath.
Flatcracker Software announced the release of Lady Biz 3.0, a specially designed iPhone application that enables women to record and track vital daily health details including menstruation details, sleep patterns, waking temperature, weight, and more.
NPR's "All Things Considered" examines HIV/AIDS treatment progress in developing countries, where the high cost of the "triple-drug regimens that were routinely saving the lives of patients in wealthier countries," and logistical issues, such as ensuring patients would take their medication on time, led some experts to say HIV treatment was "impossible" in the earlier years of the epidemic.
Sangamo BioSciences, Inc., a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire plc, have agreed to revise their January 2012 collaboration and license agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington's disease.
Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for the use of their novel mitochondrial pore modulator, TRO40303, for cytoprotection. The patent provides coverage for the use of Trophos' TRO40303 to reduce the cardiac reperfusion injury that contributes significantly to the morbidity and mortality seen after a heart attack (myocardial infarction - MI).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Muneeb Rahman, MD 246 Pleasant St Bldg West, Concord, NH 03301-2548 Ph: (603) 224-9661 | Dr Muneeb Rahman, MD 246 Pleasant St Bldg West, Concord, NH 03301-2548 Ph: (603) 224-9661 |
News Archive
Aerocrine AB (STO:AEROB) today announced that Health Canada's Therapeutic Products Directorate has approved Aerocrine's NIOX MINO® technology for use in treating asthma. Canada's National Health Service may now begin using the NIOX MINO, a medical device that provides a measure of the degree of inflammation in the airways in a single breath.
Flatcracker Software announced the release of Lady Biz 3.0, a specially designed iPhone application that enables women to record and track vital daily health details including menstruation details, sleep patterns, waking temperature, weight, and more.
NPR's "All Things Considered" examines HIV/AIDS treatment progress in developing countries, where the high cost of the "triple-drug regimens that were routinely saving the lives of patients in wealthier countries," and logistical issues, such as ensuring patients would take their medication on time, led some experts to say HIV treatment was "impossible" in the earlier years of the epidemic.
Sangamo BioSciences, Inc., a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire plc, have agreed to revise their January 2012 collaboration and license agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington's disease.
Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for the use of their novel mitochondrial pore modulator, TRO40303, for cytoprotection. The patent provides coverage for the use of Trophos' TRO40303 to reduce the cardiac reperfusion injury that contributes significantly to the morbidity and mortality seen after a heart attack (myocardial infarction - MI).
› Verified 7 days ago
Patrick Cassell, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6994 | |
Dr. Michael A Ferguson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Clayton Theron Jones, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. David Scott Johnson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Dartmouth Hitchcock - Primary Care, Concord, NH 03301 Phone: 603-226-2200 | |
Frederick M Briccetti, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant Street, New Hampshire Oncology Hematology Pa, Concord, NH 03301 Phone: 603-224-2556 Fax: 603-226-5821 | |
Dr. Patrick Magnus, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Celia Ann Englander, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 281 N State St, Concord, NH 03301 Phone: 603-271-6064 |